A Multicentre Open Randomized Phase II Study of the Efficacy and Safety of Azacitidine Alone or in Combination With Lenalidomide in High-risk Myeloid Disease (High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia) With a Karyotype Including Del(5q

Cancer type: Leukemia

Phase: II

Principal Investigator: Olsnes Astrid

Country: NO

Keywords: Norway, Bergen

Status: Inclusion completed

Link to